
Bajaj Finserv Healthcare Fund - Regular (G)
Equity · Sectoral
20.39%
Last 1 year
- Exit Load
- 1.00%
- Expense Ratio
- 2.59%
- Min. AmountMin. SIP Amount
- ₹500
- Min. Lump SumMin. Lump sum
- ₹500
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹9,00,000
- IRR
- 0.000%
- Absolute Gain
- +₹0 (+0.0%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 20.4%
- Alpha
- 8.32
Holding Analysis
Equity/Debt/Cash Split
- Equity94.9%
- Debt3.3%
- Others1.8%
Market Cap Weightage
- Large Cap40.9%
- Small Cap29.9%
- Mid Cap24.5%
- Others4.6%
Sector allocation
- Healthcare89.8%
- Debt3.3%
- Materials3.2%
- Consumer Staples1.9%
- Others1.8%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Divi's Lab. | Pharmaceuticals | 8.76% |
| Sun Pharma.Inds. | Pharmaceuticals | 8.48% |
| Piramal Pharma | Pharmaceuticals | 7.11% |
| Apollo Hospitals | Healthcare | 6.44% |
| Aurobindo Pharma | Pharmaceuticals | 5.87% |
| Rubicon Research | Pharmaceuticals | 5.84% |
| Laurus Labs | Pharmaceuticals | 4.59% |
| Torrent Pharma. | Pharmaceuticals | 4.44% |
| Dr Reddy's Labs | Pharmaceuticals | 3.96% |
| Emcure Pharma | Pharmaceuticals | 3.76% |
- 8.76%
Divi's Lab.
Pharmaceuticals
- 8.48%
Sun Pharma.Inds.
Pharmaceuticals
- 7.11%
Piramal Pharma
Pharmaceuticals
- 6.44%
Apollo Hospitals
Healthcare
- 5.87%
Aurobindo Pharma
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
Bajaj Finserv Healthcare Fund - Regular (G)
- 1 Y Return
- 20.39%
- 3 Y Return
- —
- 5 Y Return
- —
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
Fund Management

Bharat Hegde
Mr. Bharat Hegde joined the Company in July 2024 as a Senior Research Analyst - Megatrends and has been actively engaged in tracking and identifying domestic and global megatrends. In addition, he is engaged in ideation, and in-depth company and sector research for equity funds on multiple sectors such as IT, Defence, Power, Capital goods and electric Utilities. Upon his appointment as Fund Manager and Key Personnel, he will assume responsibility for the management of allocated funds, while continuing his focus on sectoral and company-level research. Prior to joining the Company, he was associated with Bharti AXA Life Insurance Company Limited, Motilal Oswal Financial Services Limited, SBICAP Securities Limited, and CRISIL Global Research & Analytics. He brings over 14 years of experience, with over 10 years of experience in equity research, including stock recommendations for equity funds, conducting company and sector analysis, assisting in fundamental research on coverage companies, building and maintaining financial models, and preparing detailed research reports.
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- 8.32
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.76
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.16
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 16.65
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.09
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 51.11
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
Bajaj Finserv Healthcare Fund - Regular – Regular Plan - Growth was launched 1 year ago and has delivered annualised returns (CAGR) of 10.46% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 20.39% 6.93% Since Inception 10.46% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of Bajaj Finserv Healthcare Fund - Regular – Regular Plan - Growth is 2.59%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
Bajaj Finserv Healthcare Fund - Regular is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in Bajaj Finserv Healthcare Fund - Regular with ₹500 a month, or invest a lump sum of ₹500. Additional investments start at ₹100.
Bajaj Finserv Healthcare Fund - Regular charges an exit load of 1% if redeemed within 3 months of investment. The exit load is deducted from the redemption amount.
No, Bajaj Finserv Healthcare Fund - Regular has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
Bajaj Finserv Healthcare Fund - Regular manages assets (AUM) of approximately ₹419 Cr.
As on 31 Oct 2026, Bajaj Finserv Healthcare Fund - Regular holds 37 securities. These are its top 10 holdings:
Company % of portfolio Divi's Lab. 8.76% Sun Pharma.Inds. 8.48% Piramal Pharma 7.11% Apollo Hospitals 6.44% Aurobindo Pharma 5.87% Rubicon Research 5.84% Laurus Labs 4.59% Torrent Pharma. 4.44% Dr Reddy's Labs 3.96% Emcure Pharma 3.76% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 89.80% Debt 3.33% Materials 3.19% Consumer Staples 1.92% Others 1.76% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the Bajaj Mutual Fund website, MF Central or KARVY. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












